Skip to main content

KBC Group NV

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1411133 Brussels, C9

Position in TEVA

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$2,106,353
+$437,284 QoQ
Shares Held
62,171
+12.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#263
of 673 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

KBC Group NV holds $54,185,094 across 22 Drug Manufacturers - Specialty & Generic names. TEVA ranks #7 (3.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 TEVA
Teva Pharmaceutical Industries Ltd
This page
62,171 $2,106,353

All Filings in TEVA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,106,353 62,171
2026-03-31 $1,669,069 55,414
2025-12-31 $1,729,470 55,414
2025-09-30 $1,119,362 55,414
2025-06-30 $928,738 55,414
2025-03-31 $721,098 46,916
2024-12-31 $819,072 37,163
2024-09-30 $467,492 25,943
2024-06-30 $421,573 25,943
2024-03-31 $366,055 25,943
2023-12-31 $158,792 15,210
2023-09-30 $218,035 21,376
2023-06-30 $160,961 21,376
2023-03-31 $112,819 12,748
2022-12-31 $116,261 12,748
2022-09-30 $102,876 12,748
2022-06-30 $95,864 12,748
2022-03-31 $119,703 12,748
2021-12-31 $102,111 12,748
2021-09-30 $394,382 40,491
2021-06-30 $262,171 26,482
2021-03-31 $305,602 26,482
2020-12-31 $255,551 26,482
2020-09-30 $238,602 26,482
2020-06-30 $326,523 26,482
2020-03-31 $430,186 47,905